We are live on
!
Find out more
C
CEDRUS Portfolio holdings
AUM
$270M
1-Year Est. Return
25.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.49%
1 Year Est. Return
+25.5%
3 Year Est. Return
+19.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
+$18M
(+14%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
41.01%
Holding
166
New
16
Increased
89
Reduced
45
Closed
9
Avg Time Held Equity + Options
3.5
quarters
Top 10 Avg Time Held Equity + Options
3.5
quarters
Top 20 Avg Time Held Equity + Options
3.6
quarters
Avg Time Held Equity only
3.6
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.6
quarters
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$1.1M |
| 2 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$391K |
| 3 |
ConocoPhillips
COP
|
+$354K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$306K |
| 5 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$263K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.92% |
| 2 | Technology | 5.2% |
| 3 | Financials | 4.74% |
| 4 | Consumer Discretionary | 3.74% |
| 5 | Healthcare | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Edwards Lifesciences
EW
$50B
| $213K | 0.15% |
2,569
-225
| -8% | -$17.7K |
2021 Q4
5 quarters
|
|
152
US Bancorp
USB
$89.5B
| $210K | 0.15% |
5,833
-126
| -2% | -$5.61K |
2022 Q4
1 quarter
|
|
153
Vanguard S&P 500 Growth ETF
VOOG
$28.4B
| $207K | 0.15% |
+5,400
| New | +$198K |
2023 Q1
0 quarters
|
|
154
First Horizon
FHN
$11.1B
| $185K | 0.13% |
10,392
| – | – |
2022 Q1
4 quarters
|
|
155
Ford
F
$48.5B
| $183K | 0.13% |
+14,484
| New | +$181K |
2023 Q1
0 quarters
|
|
156
Microvision
MVIS
$47.4M
| $66.8K | 0.05% |
1,667
+1,000
| +150% | +$37.9K |
2022 Q4
1 quarter
|
|
157
CALL
Tesla
TSLA
$1.51T
| $62 | ﹤0.01% |
300
| – | – |
2022 Q2
3 quarters
|
|
158
Blackstone
BX
$85B
| – | – |
-3,544
| Closed | -$263K | – |
|
|
159
ConocoPhillips
COP
$155B
| – | – |
-3,003
| Closed | -$354K | – |
|
160
iShares Core S&P Small-Cap ETF
IJR
$105B
| – | – |
-2,176
| Closed | -$206K | – |
|
161
Mid-America Apartment Communities
MAA
$13.7B
| – | – |
-1,343
| Closed | -$211K | – |
|
162
Altria Group
MO
$114B
| – | – |
-4,551
| Closed | -$208K | – |
|
163
Philip Morris
PM
$297B
| – | – |
-2,082
| Closed | -$211K | – |
|
164
Sherwin-Williams
SHW
$77.4B
| – | – |
-899
| Closed | -$213K | – |
|
|
XIFR
165
XPLR Infrastructure LP
XIFR
$980M
| – | – |
-3,044
| Closed | -$213K | – |
|
|
AQGX
166
DELISTED
AI Quality Growth ETF
AQGX
| – | – |
-10,673
| Closed | -$130K | – |
|
Similar funds
MFG
T
BWM
IF
BFA
CHA
FSI
S
CEDRUS's Q1 2023 Portfolio in Review
As of Q1 2023, CEDRUS held 166 positions worth $142M, up 14% from $124M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
CEDRUS deployed $13.3M of net new capital in Q1 2023, opening 16 new positions and adding to 89 existing holdings. Its largest new stake was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF: 22,877 shares worth $1.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, up from 69% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Value ETF, an estimated $1.1M trimmed.
- CEDRUS's largest Q1 2023 buy was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF: 22,877 shares worth $1.1M.
- CEDRUS added most to First Trust Rising Dividend Achievers ETF in Q1 2023, an estimated $1.38M increase.
- CEDRUS's biggest Q1 2023 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $1.1M.
- CEDRUS fully exited ConocoPhillips in Q1 2023, selling an estimated $354K.
- CEDRUS's ten largest holdings make up 41% of its $142M portfolio in Q1 2023.
- CEDRUS opened 16 new positions and closed 9 in Q1 2023.
- CEDRUS's portfolio value rose 14% quarter-over-quarter to $142M.
Based on CEDRUS's 13F filing for Q1 2023, filed 24 Jan 2024.